WONDERLAB’s “Lightness Journey Season” Opens in Chengdu, with 700 Million Bottles Sold Reflecting the Power of Science-Based Weight Management

From September 13 to 14, 2025, WONDERLAB hosted the two-day “Lightness Journey Season” event in Chengdu. The lively program combined a brand marketplace with public science sessions. It attracted enthusiastic participation from consumers while also bringing together industry guests, experts and experienced brand users to focus on weight-management challenges and pain points, and to explore the potential role of targeted gut microbiota in weight management and intestinal-barrier research. The event centered on “The Gut-Winning Code for Reclaiming a Lighter, Better State.”

As a representative company in the probiotic sector’s weight-management field, WONDERLAB invited Xiaoxiaoyu, dean of HiC Peiban Academy, and WONDERLAB representatives to the event. Through on-site interaction and professional interpretation, the participants helped the public build a more science-based understanding of weight management.

Targeted Gut Microbiota Management: A Scientific Key to Addressing Weight-Management Challenges

The 2025 report from the World Obesity Federation states that 41% of adults in China had a high BMI in 2025 and that 9% were living with obesity; by 2030, the number of adults in China with overweight or obesity is projected to reach 515.04 million. Against this backdrop, China’s National Health Commission, together with 15 other ministries and departments, launched a three-year “Weight Management Year” initiative in June 2024. The initiative called for a “scientific and precise intervention” framework for weight management and encouraged a shift in health management from “disease treatment” toward “whole-life-cycle health management.” Relevant research has linked gut-microbiota imbalance with obesity, and people with lower gut-microbiota diversity may be more likely to experience obesity-related conditions. At the event, a WONDERLAB R&D expert explained the relationship between gut microbiota and weight management: “The key to weight management lies in gut microbiota. An imbalance can disrupt metabolism—when beneficial bacteria decrease, the protective layer of the intestinal wall may lose its integrity like a damaged barrier. Harmful substances entering the bloodstream can then trigger chronic inflammation in adipose tissue and reduce metabolic activity. Clinical data show that this process can seriously affect the body’s ability to process glucose, leaving people caught in the metabolic dilemma of ‘the more weight one gains, the harder it is to lose.’”

The expert continued: “WONDERLAB’s Targeted Gut Microbiota Management Method™ uses the multiple effects of gut-microbiota characteristics on energy balance. By using gut microbiota as a precise target and applying specific probiotics, prebiotics and other microecological regulators, it guides the gut-microbiota structure of the person receiving the intervention to play a positive role at different stages of energy balance, thereby improving the effectiveness of weight management.” Of particular note, WONDERLAB’s morning-and-evening probiotic pairing—BODY100 PLUS™ in the morning and SHAPE100 PLUS™ in the evening—offers consumers another option for weight-management support. SHAPE100 PLUS™ uses a dual-track technical approach combining proprietary strains with strains recognized under the European Food Safety Authority’s Qualified Presumption of Safety (QPS) framework. It contains the independently developed *Lactobacillus acidophilus* strain GOLDGUT-LA100, together with a combination of QPS-recognized strains, prebiotics and functional ingredients positioned for weight-management support. The product was reported to rank at the top of major e-commerce sales lists after launch and became a widely followed product in the market.

700 Million-Bottle Sales Milestone: Science-Based Evidence Builds Market Trust

During the brand presentation at the event, WONDERLAB announced that sales of its probiotic products had surpassed 700 million bottles. The milestone represented not only a numerical increase but also the result of the brand’s long-term work in the probiotic sector and, as the announcement presented it, strong market recognition of its products and approach.

“The 700 million-bottle sales milestone comes from WONDERLAB’s firm commitment to the idea that ‘R&D is the lifeline,’” the company said. As market needs continue to change, the company believes that only long-term scientific work can respond precisely to consumers’ health-related needs. WONDERLAB has consistently used “clinical testing” and an “evidence-based approach” as core principles for product development, presenting them as a reference point for the sector. From the launch of its first adult broad-spectrum “Blue Bottle” probiotic in 2020 to the 2025 4.0 version featuring the proprietary patented strain GOLDGUT-M520 and positioned around “barrier repair,” the brand’s “Golden Gut System” was presented as setting a new industry reference. This six-year history of iteration was described as a vivid reflection of the Chinese probiotic industry’s transition from “domestic substitution” to “standard-setting.” WONDERLAB has established a closed-loop, end-to-end R&D model spanning “basic research, strain screening, clinical validation and industrial translation,” using its research capabilities to drive product innovation.

Industry observers said WONDERLAB’s success was not accidental. In their view, the brand used robust scientific evidence to challenge the perception that “probiotics are an IQ tax,” broadened probiotic applications through cross-sector integration, and opened a sustainable development path for China’s probiotic sector built on technology and data. This, they said, demonstrates that only science-based and clinically informed approaches can genuinely respond to consumers’ health needs. As more companies like WONDERLAB place emphasis on research and innovation, China’s probiotic sector is moving toward greater standardization and healthier development. The health value of probiotics, the article concludes, will be recognized, accepted and trusted by more consumers.